Management of Menstrual Migraine: A Review of Current Abortive and Prophylactic Therapies

Sullivan, Elizabeth; Bushnell, Cheryl

doi:10.1007/s11916-010-0138-2

Cited by 15 publications

(14 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to literature, common migraine is more prevalent than classic migraine (90% versus 10%) [17]. It is also more common and more painful in females' population [18] similar to what was seen in our study.…”

Section: Discussionsupporting

confidence: 91%

Is Low Dose Combination Therapy Effective for Migraine Prophylaxis ? A Case Series Study

Karamimagham

Poursadeghfard

2016

Zahedan J Res Med Sci

View full text Add to dashboard Cite

Introduction:The aim of this case series study was to determine whether the lower starting doses of prophylactic antimigraine drugs are as effective as the recommended standard regimen when used in combination without increment. Methods:In this retrospective case series study, we reported old charts of previously visited patients with migraine headache who needed prophylaxis in Shiraz, south of Iran. All medications used in these patients were started as combination of two drugs with the lower doses than mentioned in the literature. Descriptive statistics were used for data analysis.Results: Three patients (7.5%) did not respond to medications and 7 (18.75%) showed a very good response (more than 70% recovery in pain severity). Overall, 29 patients (72%) responded with at least 50% recovery after treatment. Conclusions:Our results showed lower doses of migraine prophylactic drugs can be effective with the least side effects and the most tolerance for patients. This case series report can be useful in designing further studies; however, no causal inferences should be made from it regarding the efficacy of the investigated treatment.

show abstract

Section: Discussionsupporting

confidence: 91%

Is Low Dose Combination Therapy Effective for Migraine Prophylaxis ? A Case Series Study

Karamimagham

Poursadeghfard

2016

Zahedan J Res Med Sci

View full text Add to dashboard Cite

show abstract

“…For example, menstrual migraine, migraine without aura associated with each menstrual period, is likely related to decreasing levels of estrogen in the luteal phase; 91,92 this syndrome represents 50% to 60% of women with migraines. 93 The incidence of migraine without aura during pregnancy decreases as the pregnancy progresses in most women.…”

Section: Gender Differences In Treatmentmentioning

confidence: 99%

Gender Differences in Neurologic Emergencies Part I: A Consensus Summary and Research Agenda on Cerebrovascular Disease

Madsen

Seigel²,

Mackenzie

et al. 2014

Acad Emerg Med

View full text Add to dashboard Cite

Cerebrovascular neurologic emergencies including ischemic and hemorrhagic stroke, subarachnoid hemorrhage (SAH), and migraine are leading causes of death and disability that are frequently diagnosed and treated in the emergency department (ED). Although sex and gender differences in neurologic emergencies are beginning to become clearer, there are many unanswered questions about how emergency physicians should incorporate sex and gender into their research initiatives, patient evaluations, and overall management plans for these conditions. After evaluating the existing gaps in the literature, a core group of ED researchers developed a draft of future research priorities. Participants in the 2014 Academic Emergency Medicine consensus conference neurologic emergencies working group then discussed and approved the recommended research agenda using a standardized nominal group technique. Recommendations for future research on the role of sex and gender in the diagnosis, treatment, and outcomes pertinent to ED providers are described for each of three diagnoses: stroke, SAH, and migraine. Recommended future research also includes investigation of the biologic and pathophysiologic differences between men and women with neurologic emergencies as they pertain to ED diagnoses and treatments.ACADEMIC EMERGENCY MEDICINE 2014;21:1403-1413 by the Society for Academic Emergency Medicine C erebrovascular neurologic emergencies such as ischemic and hemorrhagic stroke, subarachnoid hemorrhage (SAH), and migraine are among the most lethal and disabling conditions presenting to the emergency department (ED). We have made great strides in understanding and treating these conditions, and our efforts have led to improved outcomes for these patients. Sex-and gender-based distinctions, however, are only recently becoming clearer, and much work is needed to explain the differences observed between men and women. After a focused review of the current literature on preclinical, clinical, and outcomes differences between women and men, and then the consensus process, we propose a research agenda in the areas of stroke, SAH, and headache/migraine. METHODSAfter evaluating the current literature, the authors, all emergency medicine (EM) researchers, proposed an agenda for future research. Consensus was reached using an iterative process through the four-part nominal group technique as already described in the executive summary. 1 A multidisciplinary group of participants (EM, critical care medicine, internal medicine, physical and rehabilitation medicine) prioritized the final iteration of themes/questions using the Poll Everywhere Web-based voting method. Descriptive statistics were calculated to tabulate the final list of questions presented below. The proposed research questions were then discussed and voted on by participants in the Academic Emergency Medicine consensus conference neurologic emergencies working group (see footnote for listing) at the meeting in May 2014. STROKE Epidemiology/OutcomesStroke is the fourth leading ca...

show abstract

“…Anecdotally, non‐oral triptan formulations reportedly are particularly difficult to obtain, causing patients with substantial vomiting to consider emergency department visits to receive parenteral fluids and pain management. Finally, although good quality evidence supports the use of triptans to prevent attacks of menstrual migraine, the drugs are not FDA‐approved for that indication and this “off‐label” status is often cited as a barrier to obtaining prescription coverage for them. If confirmed, this limitation would represent a serious treatment disparity for women with migraine.…”

Section: Generic and Brand Name Triptan Formulations Available In Thementioning

confidence: 99%

Variation in Prescription Drug Coverage for Triptans: Analysis of Insurance Formularies

et al. 2017

View full text Add to dashboard Cite

show abstract

Management of Menstrual Migraine: A Review of Current Abortive and Prophylactic Therapies

Cited by 15 publications

References 36 publications

Is Low Dose Combination Therapy Effective for Migraine Prophylaxis ? A Case Series Study

Is Low Dose Combination Therapy Effective for Migraine Prophylaxis ? A Case Series Study

Gender Differences in Neurologic Emergencies Part I: A Consensus Summary and Research Agenda on Cerebrovascular Disease

Variation in Prescription Drug Coverage for Triptans: Analysis of Insurance Formularies

Contact Info

Product

Resources

About